MAPT and Alzheimer disease: Subcutaneous implantation of ECT for passive immunization against amyloid-beta has been found efficacious in mouse models for Alzheimer disease (Lathuilière et al., 2016; Xu et al., 2020) to reduce brain amyloid and tau pathologies.